Numerous signal transduction pathways, downstream of tyrosine kinases, bifurcate on key serine/threonine kinases, which phosphorylate effector molecules to potentiate the emergence of aggressive cancers and the establishment of an immunosuppressive tumor microenvironment. The gene discussed is MARK2; the disease is cancer.